(Q67987735)
Statements
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study (English)
Acocella G
Nonis A
Perna G
Patane E
Gialdroni-Grassi G
1 October 1988